Indefinite Delivery Contract SPE2DB22D9251

The Defense Logistics Agency awarded an indefinite-delivery/indefinite-quantity contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies in support of DLA and Department of Defense operations. Over the period of performance from April 2022 through December 2025, DMS Pharmaceutical Group Inc. serves as the prime contractor fulfilling delivery orders against the contract for items including botulinum toxin, contraceptive implants, vaccines, intrauterine devices, and other medical commodities. Task orders issued by DLA to DMS Pharmaceutical Group Inc. under the contract have included firm fixed price delivery orders ranging from approximately $10 to over $90,000 to supply pharmaceuticals and medical supplies from DMS Pharmaceutical Group Inc.'s facility in Park Ridge, Illinois for use in DLA's medical logistics programs. No set aside designations were applied to orders issued pursuant to this IDV contract aimed at supporting the procurement of critical pharmaceutical and medical supplies for Department of Defense medical treatment facilities and personnel worldwide.

The indefinite-delivery/indefinite-quantity contract awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. establishes the prime vendor arrangement whereby DLA fulfills its mandate to provide logistical support for Department of Defense medical readiness programs through the issuance of delivery orders against the contract over its three year period of performance. Task orders issued under the contract range in value and period of performance and supply various pharmaceutical products and medical supplies from DMS Pharmaceutical Group Inc.'s Illinois facility to support DLA's global supply chain responsibilities in equipping military treatment networks.